← All candidates
1 insider filing on record.
2 filings on record.
ATOSATOSSA THERAPEUTICS, INC.
—
1 insider filing on record.
None of them an open-market buy in the last year.
No price data yet — the yfinance scanner hasn't produced bars for ATOS.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.95 act+$0.15
Q1 '26−$1.11 act+$0.11
Q4 '25−$1.34 act−$0.20
Q3 '25−$1.05 act−$0.05
The file stays open
2 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice